# Aligos Therapeutics, Inc.: Form SC 13D/A, filed Jan 31, 2022

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: SC 13D/A
- Filed: 2022-01-31
- Accepted by EDGAR: Jan 31, 2022, 16:28 ET
- Period: not reported
- Accession: 0001193125-22-023399
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312522023399/d306544dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312522023399/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312522023399/d306544dsc13da.htm

Filed Jan 31, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-023399. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.